CAS 1365888-06-7

2-Propenoic acid, 3-[4-[(1E)-2-(2-chloro-4-fluorophenyl)-1-(1H-indazol-5-yl)-1-buten-1-yl]phenyl]-, (2E)-

CAS: 1365888-06-7

Fórmula: C₂₆H₂₀ClFN₂O₂

Pureza: %

Cor e Forma: Solid

Peso molecular: 446.9006

Ref: IN-DA00123J

(E)-3-(4-((E)-2-(2-Chloro-4-Fluorophenyl)-1-(1H-Indazol-5-Yl)But-1-En-1-Yl)Phenyl)Acrylic Acid

CAS: 1365888-06-7

(E)-3-(4-((E)-2-(2-Chloro-4-Fluorophenyl)-1-(1H-Indazol-5-Yl)But-1-En-1-Yl)Phenyl)Acrylic Acid

Pureza: 98+%

Peso molecular: 446.9g/mol

Ref: 54-PC108766

Brilanestrant

CAS: 1365888-06-7

Brilanestrant

Pureza: ≥98%

Peso molecular: 446.9g/mol

Ref: 54-BUP08565

Brilanestrant

CAS: 1365888-06-7

Fórmula: C₂₆H₂₀ClFN₂O₂

Peso molecular: 446.91

Ref: 4Z-B-170001

Brilanestrant

CAS: 1365888-06-7

Brilanestrant (GDC-0810) is a selective estrogen receptor degrader (IC50: 0.7 nM).

Fórmula: C₂₆H₂₀ClFN₂O₂

Pureza: 99.07% - 99.17%

Cor e Forma: Solid Powder

Peso molecular: 446.9

Ref: TM-T5118

GDC 0810

CAS: 1365888-06-7

Estrogen receptor degrader; therapeutic use in breast cancer

Fórmula: C₂₆H₂₀ClFN₂O₂

Pureza: Min. 95%

Cor e Forma: Powder

Peso molecular: 446.9 g/mol

Ref: 3D-FG137678